Italy Ophthalmic Devices Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Italy's ophthalmic devices market represents a significant segment within the broader European ophthalmology sector, which collectively reached multi-billion-dollar valuations in 2025. The Italian market encompasses surgical equipment, diagnostic imaging systems, implants, consumables, and vision care products, though no government statistical agency publishes an official standalone figure for its size. It functions as one of the larger national markets in Europe, supported by a well-established healthcare infrastructure and high per-capita healthcare spending.

• •Valued at $1.59 billion in 2025, with projections extending to $2.25 billion by 2031 under a 5.95% CAGR scenario
• •No direct official government-published standalone market size figure exists, with market estimates sourced from commercial industry analyses
• •Sits within the broader European ophthalmic devices market valued at approximately $5.47 billion in 2025

A principal catalyst for market expansion is the rising prevalence of diabetic retinopathy across Italy's population, increasing demand for diagnostic imaging and treatment devices. The country's demographic profile, marked by one of the oldest populations in Europe, sustains elevated demand for cataract surgery equipment, intraocular lenses, and age-related macular degeneration treatments. High per-capita healthcare spending and Italy's universal healthcare system further support adoption of advanced ophthalmic technologies.

• •Rising diabetic retinopathy prevalence drives demand for diagnostic imaging and treatment solutions
• •Italy's aging demographic sustains long-term demand for cataract devices, intraocular lenses, and AMD therapies
• •High healthcare spending and universal coverage support steady adoption of advanced ophthalmic technologies

Within the Italian market, optical coherence tomography scanners represent the largest revenue-generating product segment, underscoring the critical role of diagnostic imaging. The market also includes surgical devices, implants, consumables, and vision care products. Italy is identified as a key constituent of the broader European ophthalmic market, which is projected to expand at a compound annual growth rate near 8.7 percent from 2026 through 2033.

• •Optical coherence tomography scanners are the largest revenue-generating product segment
• •Product categories include surgical devices, implants, consumables, and vision care alongside diagnostic imaging
• •The broader European ophthalmic market is forecast to grow at approximately 8.7% CAGR from 2026 to 2033

What are the recent trends and outlook?

The market is expected to maintain steady growth through 2031, supported by continued aging demographics, technological advancements in minimally invasive surgical techniques, and expanding use of digital health tools in ophthalmology. Adoption of artificial intelligence-assisted diagnostics and remote monitoring capabilities is gradually influencing product development priorities among manufacturers serving the Italian market. Over the longer horizon through 2035, combined ophthalmic drugs and devices markets in Italy are modeled at compound annual growth rates in the range of 5 to 6 percent.

• •Technological advancements in minimally invasive surgical procedures and AI-assisted diagnostics are reshaping product development
• •The market is projected to reach $2.25 billion by 2031 based on prevailing 5.95% CAGR estimates
• •Longer-term combined drug and device forecasts through 2035 indicate sustained growth in the 5-6% annual range